Axogen (AXGN) Change in Receivables (2010 - 2026)
Axogen's (AXGN) quarterly Change in Receivables came in at $2.0 million in Q1 2026, down 14.85% year-on-year from $2.4 million in Q1 2025, and up 144.35% quarter-over-quarter from -$4.6 million in Q4 2025.
Axogen (AXGN) Change in Receivables (2010 - 2026) Analysis & Trends
Axogen's Change in Receivables history runs 17 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- On a quarterly basis, Change in Receivables fell 14.85% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $2.1 million, a 20.82% decrease from a year earlier, with the FY2025 full-year figure at $2.5 million, up 728.57% from the prior year.
- Change in Receivables improved to $2.0 million in Q1 2026 per AXGN's latest filing, from -$4.6 million in the prior quarter.
- Across five years, Change in Receivables topped out at $2.7 million in Q3 2025 and bottomed at -$4.6 million in Q4 2025.
- The 5-year median for Change in Receivables is $976000.0 (2022), against an average of $672117.6.
- Biggest YoY gain for Change in Receivables was 706.7% in 2025; the steepest drop was 856.81% in 2025.
- Year by year, Change in Receivables stood at $944000.0 in 2022, then soared by 103.92% to $1.9 million in 2023, then plunged by 124.78% to -$477000.0 in 2024, then slumped by 856.81% to -$4.6 million in 2025, then soared by 144.35% to $2.0 million in 2026.
- Per Business Quant, the three latest AXGN Change in Receivables figures stand at $2.0 million (Q1 2026), -$4.6 million (Q4 2025), and $2.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn | 2.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.02 Mn |
| Mar 31, 2026 | 2.02 Mn |
| Dec 31, 2025 | -4.56 Mn |
| Dec 31, 2025 | -4.56 Mn |
| Sep 30, 2025 | 2.72 Mn |
| Sep 30, 2025 | 2.72 Mn |
| Jun 30, 2025 | 1.93 Mn |
| Jun 30, 2025 | 1.93 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Mar 31, 2025 | 2.38 Mn |
| Dec 31, 2024 | -477,000.00 |
| Dec 31, 2024 | -477,000.00 |
| Sep 30, 2024 | -448,000.00 |
| Sep 30, 2024 | -448,000.00 |
| Jun 30, 2024 | 1.21 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | -681,000.00 |
| Mar 31, 2024 | -681,000.00 |
| Dec 31, 2023 | 1.93 Mn |
| Dec 31, 2023 | 1.93 Mn |